Novozymes and Terranol to market advanced biofuel yeast
Novozymes and Terranol, a Denmark-based biotechnology company specialized in yeast, announced an agreement that will ensure the final optimization of the Terranol C5 yeast strain and give Novozymes the rights to register and market Terranol’s C5 yeast technology. C5 yeast is an essential component in the production of cellulosic ethanol, and the partnership will allow Novozymes to speed up global rollout of Terranol’s yeast to customers in the cellulosic ethanol industry. Wide availability of a high-performing and cost-efficient yeast will enable the nascent industry to fast-track the transition from today’s demonstration-scale production to large-scale commercialization.
“We want to make sure there are no biotech-related hurdles to the creation of a cellulosic ethanol industry,” says Poul Ruben Andersen, Vice President Bioenergy at Novozymes. “Terranol’s C5 yeast is currently one of the best strains developed, and by getting it registered and marketed around the world, we can help make it available to the biofuel industry. This will provide a higher degree of certainty in the commercialization of cellulosic ethanol.”
“With our combined R&D capabilities we can ensure the final optimization of the strain in order to achieve maximum economic performance for our cellulosic ethanol customers,” says Claus Crone Fuglsang, Vice President R&D at Novozymes.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
